66 related articles for article (PubMed ID: 19841179)
1. A murine model for human early/immature T-cell precursor acute lymphoblastic leukemia (EITP ALL).
Negi V; Aplan PD
Oncoscience; 2022; 9():60-63. PubMed ID: 36330381
[TBL] [Abstract][Full Text] [Related]
2. The Coming of Age of Preclinical Models of MDS.
Liu W; Teodorescu P; Halene S; Ghiaur G
Front Oncol; 2022; 12():815037. PubMed ID: 35372085
[TBL] [Abstract][Full Text] [Related]
3. Oncogene-Induced Reprogramming in Acute Lymphoblastic Leukemia: Towards Targeted Therapy of Leukemia-Initiating Cells.
Fregona V; Bayet M; Gerby B
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771671
[TBL] [Abstract][Full Text] [Related]
4. Cell-Extrinsic Differentiation Block Mediated by EphA3 in Pre-Leukaemic Thymus Contributes to Disease Progression.
Pliego Zamora AC; Ranasinghe H; Lisle JE; Ng CK; Huang S; Wadlow R; Scott AM; Boyd AW; Slape CI
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359759
[TBL] [Abstract][Full Text] [Related]
5. Altered follicular helper T cell impaired antibody production in a murine model of myelodysplastic syndromes.
Jiang H; Cui N; Yang L; Liu C; Yue L; Guo L; Wang H; Shao Z
Oncotarget; 2017 Nov; 8(58):98270-98279. PubMed ID: 29228688
[TBL] [Abstract][Full Text] [Related]
6. The fusion partner specifies the oncogenic potential of NUP98 fusion proteins.
Saw J; Curtis DJ; Hussey DJ; Dobrovic A; Aplan PD; Slape CI
Leuk Res; 2013 Dec; 37(12):1668-73. PubMed ID: 24090997
[TBL] [Abstract][Full Text] [Related]
7. Isolated Hoxa9 overexpression predisposes to the development of lymphoid but not myeloid leukemia.
Beachy SH; Onozawa M; Silverman D; Chung YJ; Rivera MM; Aplan PD
Exp Hematol; 2013 Jun; 41(6):518-529.e5. PubMed ID: 23435313
[TBL] [Abstract][Full Text] [Related]
8. Non-homologous end joining mediated DNA repair is impaired in the NUP98-HOXD13 mouse model for myelodysplastic syndrome.
Puthiyaveetil AG; Reilly CM; Pardee TS; Caudell DL
Leuk Res; 2013 Jan; 37(1):112-6. PubMed ID: 23131583
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling and candidate gene resequencing identifies pathways and mutations important for malignant transformation caused by leukemogenic fusion genes.
Novak RL; Harper DP; Caudell D; Slape C; Beachy SH; Aplan PD
Exp Hematol; 2012 Dec; 40(12):1016-27. PubMed ID: 22885519
[TBL] [Abstract][Full Text] [Related]
10. Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma.
Beachy SH; Onozawa M; Chung YJ; Slape C; Bilke S; Francis P; Pineda M; Walker RL; Meltzer P; Aplan PD
Blood; 2012 Aug; 120(5):1048-59. PubMed ID: 22723554
[TBL] [Abstract][Full Text] [Related]
11. Depletion of cytotoxic T-cells does not protect NUP98-HOXD13 mice from myelodysplastic syndrome but reveals a modest tumor immunosurveillance effect.
Gough SM; Chung YJ; Aplan PD
PLoS One; 2012; 7(5):e36876. PubMed ID: 22606303
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of rodent immune and hematopoietic system reactive lesions from neoplasias.
Ward JM; Rehg JE; Morse HC
Toxicol Pathol; 2012 Apr; 40(3):425-34. PubMed ID: 22215512
[TBL] [Abstract][Full Text] [Related]
13. NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights.
Gough SM; Slape CI; Aplan PD
Blood; 2011 Dec; 118(24):6247-57. PubMed ID: 21948299
[TBL] [Abstract][Full Text] [Related]
14. Mouse models of myelodysplastic syndromes.
Beachy SH; Aplan PD
Hematol Oncol Clin North Am; 2010 Apr; 24(2):361-75. PubMed ID: 20359631
[TBL] [Abstract][Full Text] [Related]
15. A NUP98-HOXD13 fusion gene impairs differentiation of B and T lymphocytes and leads to expansion of thymocytes with partial TCRB gene rearrangement.
Choi CW; Chung YJ; Slape C; Aplan PD
J Immunol; 2009 Nov; 183(10):6227-35. PubMed ID: 19841179
[TBL] [Abstract][Full Text] [Related]
16. Thymic precursor cells generate acute myeloid leukemia in NUP98-PHF23/NUP98-HOXD13 double transgenic mice.
Kundu S; Park ES; Chung YJ; Walker RL; Zhu YJ; Negi V; Meltzer PS; Aplan PD
Sci Rep; 2019 Nov; 9(1):17213. PubMed ID: 31748606
[TBL] [Abstract][Full Text] [Related]
17. Mutant
Goldberg L; Negi V; Chung YJ; Onozawa M; Zhu YJ; Walker RL; Pierce R; Patel DP; Krausz KW; Gonzalez FJ; Goodell MA; Rodriguez BAT; Meltzer PS; Aplan PD
Cancer Res; 2021 Oct; 81(19):5033-5046. PubMed ID: 34321240
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
